Last reviewed · How we verify
NCT03958825
Open Versus Laparoscopic Left Hepatic Sectionectomy
NA trial testing laparoscopic hepatic sectionectomy in Hepatolithiasis in 88 participants. Status unknown.
26 December 2022
Quick facts
| Lead sponsor | The Second Hospital of Anhui Medical University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 88 |
| Start date | 10 August 2019 |
| Primary completion | 26 December 2022 |
| Estimated completion | 1 June 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- laparoscopic hepatic sectionectomy
- open left hepatic sectionectomy
Conditions studied
- Hepatolithiasis — all drugs for Hepatolithiasis →
- Laparoscopic Liver Resection — all drugs for Laparoscopic Liver Resection →
- Open Liver Resection — all drugs for Open Liver Resection →
- Enhanced Recovery — all drugs for Enhanced Recovery →
Sponsor
The Second Hospital of Anhui Medical University
Who can join
Adults 18 to 80, any sex, with Hepatolithiasis or Laparoscopic Liver Resection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Laparoscopic left sectionectomy has been associated with shorter hospital stay and reduced overall morbidity compared with open left sectionectomy. Strong evidence has not, however, been provided.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Total laparoscopic partial hepatectomy versus open partial hepatectomy for primary left-sided hepatolithiasis: study protocol for a randomized controlled trial.
Pan SB, Wu CL, Zhou DC, Xiong QR, et al · · 2024 · cited 2× · PMID 38383461 · DOI 10.1186/s13063-023-07476-w -
Total Laparoscopic Partial Hepatectomy Versus Open Partial Hepatectomy For Primary Left-Sided Hepatolithiasis: Study Protocol For A Randomized Controlled Trial
Pan S, Wu C, Zhou D, Xiong Q, et al · · 2021 · DOI 10.21203/rs.3.rs-17346/v2
Verify or expand the search:
- PubMed search for NCT03958825
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other The Second Hospital of Anhui Medical University trials
Trials by the same sponsor.
- NCT07533773 — Investigating Functional Changes in the Frontotemporal Cortex of Patients With Major Depressive Disorder Following Elect · NA · not yet recruiting
- NCT07500064 — Transcranial Direct Current Stimulation for Depression · NA · not yet recruiting
- NCT07373132 — Effects of Aromatherapy on Sleep Quality in Hospitalized Elderly Female Patients With Insomnia · NA · not yet recruiting
- NCT07185022 — Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion · NA · recruiting
- NCT07023679 — Stellate Ganglion Morphine Infiltration on Myocardial I/R Injury · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03958825 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Second Hospital of Anhui Medical University
- Last refreshed: 18 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03958825.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing